Local excision of early rectal cancer: A multi-centre experience of transanal endoscopic microsurgery from the United Kingdom.

World journal of gastrointestinal surgery 2024 Vol.16(10) p. 3114-3122

Farid A, Tutton M, Thambi P, Gill TS, Khan J

관련 도메인

Abstract

[BACKGROUND] Total mesorectal excision remains the gold standard for the management of rectal cancer however local excision of early rectal cancer is gaining popularity due to lower morbidity and higher acceptance by the elderly and frail patients.

[AIM] To investigate the results of local excision of rectal cancer by transanal endoscopic microsurgery (TEMS) approach carried out at three large cancer centers in the United Kingdom.

[METHODS] TEMS database was retrospectively reviewed to assess demographics, operative findings and post operative clinical and oncological outcomes. This is a retrospective review of the prospective databases, which included all patients operated with TEMS approach, for early rectal cancer (Node-negative T1-T2), selected T3 in unfit/frail patients.

[RESULTS] Two hundred and twenty-two patients underwent TEMS surgery. This included 144 males (64.9%) and 78 females (35.1%), Median age was 71 years. The median distance of the tumours from the anal verge 4.5 cm. Median tumour size was 2.6 cm. The most frequent operative position of the patient was lithotomy (32.3%), Full-thickness rectal wall excision was done in 204 patients. Median operating time was 90 minutes. Average blood loss was minimal. There were two 90-day mortalities. Complete excision of the tumour with free microscopic margins by > 1mm were accomplished in 171 patients (76.7%). Salvage total mesorectal excision was performed in 42 patients (19.8%). Median disease-free survival was 65 months (range: 3-146 months) (82.8%), and median overall survival was 59 months (0-146 months).

[CONCLUSION] TEMS provides a promising option for early rectal cancers (Large adenomas-cT1/cT2N0), and selected therapy-responding cancers. Full-thickness complete excision of the tumour is mandatory to avoid jeopardising the oncological outcomes.

추출된 의학 개체 (NER)

유형영어 표현한국어 / 풀이UMLS CUI출처등장
시술 microsurgery 미세수술 dict 2
기법 endoscopic 내시경 dict 2
해부 blood scispacy 1
합병증 anal verge scispacy 1
약물 90-day scispacy 1
약물 [BACKGROUND] Total mesorectal excision remains scispacy 1
약물 [RESULTS] Two scispacy 1
질환 cancer C0006826
Malignant Neoplasms
scispacy 1
질환 rectal cancer C0007113
Rectal Carcinoma
scispacy 1
질환 Node-negative C0678034
Negative Lymph Node
scispacy 1
질환 tumour C0027651
Neoplasms
scispacy 1
질환 blood loss C0019080
Hemorrhage
scispacy 1
질환 cancers C0006826
Malignant Neoplasms
scispacy 1
질환 Node-negative T1-T2 scispacy 1
질환 tumours scispacy 1
질환 rectal cancers scispacy 1
질환 therapy-responding cancers scispacy 1
기타 patients scispacy 1
기타 patient scispacy 1
기타 Full-thickness rectal wall scispacy 1

🔗 함께 등장하는 도메인

이 논문이 속한 카테고리와 같은 논문에서 자주 함께 다뤄지는 카테고리들

관련 논문